The FASEB Journal, Vol 5, 2287-2291, Copyright © 1991 by The Federation of American Societies for Experimental Biology

REVIEWS

Immunomodulating activity of heparin

A Gorski, M Wasik, M Nowaczyk and G Korczak-Kowalska
Department of Immunology, Warsaw Medical School, Poland.

Aside from its well-known anticoagulant action, heparin has many other biologic effects. Recent data emphasize the immunomodulatory effects of low dose heparin. The agent alters the traffic of lymphocytes blocking their expression of heparanase, an enzyme that digests the extracellular matrix allowing cell penetration to target tissues. It also has a weak direct immunosuppressive action in vitro and in vivo. Oral administration of heparin may cause immunosuppression, although the effects are weaker than after subcutaneous administration.

This article has been cited by other articles:

				D. Hasdai, N. Varda-Bloom, N. Blumberg, D. Ohad, R. Kornowski, and A. Battler The Effect of Low Molecular Weight Heparin (Fragmin) on Myocardial Neutrophil Accumulation and Infarct Size in a Rat Model of Myocardial Infarction Angiology, May 1, 1996; 47(5): 491 - 499. [Abstract] [PDF]

				H. Engelberg Orally Ingested Heparin Is Absorbed in, Humans Clinical and Applied Thrombosis/Hemostasis, September 1, 1995; 1(4): 283 - 285. [Abstract] [PDF]